More than 13 years after its initial FDA approval, Pfizer’s blood cancer drug Adcetris has nabbed another regulatory green light...
New data from the UK Health Security Agency (UKHSA) indicates significant progress in combating meningitis caused by meningococcal...
After a month-long clinical hold, Novavax has received the green light from the US Food and Drug Administration (FDA) to resume cl...